R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Director, Marketing

Marketing Generalist & ManagementPosted on Nov 10
Full-timeMilan, Metropolitan City of Milan, ItalyNo salary listed

About the Job

Requirements

  • An advanced degree, such as an MBA, PhD, MD, or equivalent, in biotechnology, life sciences, business administration, or another relevant field is required.
  • At least 10 years of experience in the biotech or pharmaceutical industry, including marketing, sales, or product planning experience focused on oncology.
  • A successful track record launching and commercializing products in Italy is required.
  • Ability to collaborate with cross-functional teams in an international setting is required.
  • Strong analytical, problem-solving, planning, organizational, technical, and project management skills are required.
  • Excellent written, verbal, presentation, customer interaction, and interpersonal communication skills are required.
  • Ability to develop and maintain relationships with healthcare professionals and other external stakeholders is required.
  • Ability to translate scientific understanding and customer insights into creative, effective promotional approaches is required.
  • Ability to operate independently and execute strategic and tactical plans under tight timelines is required.
  • Ability to manage ambiguity, evolving priorities, and financial budgets in a fast-growing organization is required.
  • Ability to deliver compelling presentations to individuals and groups, adapting messaging to maximize engagement, is required.
  • High proficiency in Microsoft Office, including PowerPoint, Excel, and Word, is required.
  • Willingness to travel as needed is required.

Responsibilities

  • Build and lead the marketing function responsible for developing and executing commercialization strategies to support product launches in Italy.
  • Work closely with local cross-functional partners, including Market Access, Sales, and Medical Affairs, to incorporate customer needs, evidence generation, pricing, reimbursement, and market dynamics into launch planning and execution.
  • Shape and execute marketing plans, translate strategic priorities into initiatives, and assess market opportunities, customer needs, treatment challenges, healthcare system dynamics, competitive developments, diagnostic barriers, and advocacy needs.
  • Lead marketing projects, including customer-facing materials, congress activities, campaigns, training resources, and field force tools.
  • Lead development and execution of marketing strategies and tactical plans supporting commercialization of the portfolio in Italy.
  • Collaborate with global, European, and local cross-functional teams, including Sales, Market Access, Medical Affairs, and commercialization partners, to maximize product value in Italy.
  • Generate market insights to inform commercial strategy, tactical execution, product forecasts, and launch planning.
  • Partner with Medical Affairs to support an integrated scientific and thought leadership strategy.
  • Localize and implement European strategy through programs and channels, including events, webinars, congresses, content, direct mail, and digital advertising.
  • Develop initiatives addressing market challenges, unmet needs, and opportunities.
  • Lead affiliate congress planning and execution in alignment with European guidelines.
  • Establish and maintain relationships with key opinion leaders, healthcare professionals, key customers, and patient advocates.
  • Develop aligned messaging, communication plans, promotional materials, scientific resources, and field force tools in line with strategic objectives.
  • Monitor market trends, competitor activity, stakeholder insights, therapeutic hurdles, and emerging opportunities.
  • Comply with laws, regulations, and policies governing the conduct of company staff.
  • Embody corporate Core Values while cultivating an energized team culture focused on patient impact.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs